Reduced-intensity conditioning regimen with ex vivo T-cell depletion after unrelated donor as stem cell source for patients with haematological malignancies

被引:0
|
作者
Castagna, L. [1 ]
Crocchiolo, R. [1 ]
Furst, S. [1 ]
El Cheikh, J. [1 ]
Esterni, B. [1 ]
Granata, A. [1 ]
Lemarie, C. [1 ]
Oudin, C. [1 ]
Faucher, C. [1 ]
Chabannon, C. [1 ]
Blaise, D. [1 ]
机构
[1] Inst J Paoli I Calmettes, F-13009 Marseille, France
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
引用
收藏
页码:S329 / S329
页数:1
相关论文
共 50 条
  • [41] Reduced-intensity conditioning regimens in allogeneic haematopoetic stem cell transplantation in children and adolescents with advanced haematological malignancies
    Semenova, E.
    Stancheva, N.
    Ovsjannikova, M.
    Zubarovskaya, N.
    Babenko, E.
    Afanasyev, B.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S299 - S299
  • [42] Nephrotic syndrome after allogeneic transplantation of haematopoietic stem cell with a reduced-intensity conditioning regimen
    Benakli, M.
    Ahmed-Nacer, R.
    Talbi, A.
    Mehdid, F.
    Belhadj, R.
    Rahmoune, N.
    Hamladji, R. M.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S279 - S279
  • [43] Impact of donor types on reduced-intensity conditioning allogeneic stem cell transplant for mature lymphoid malignancies
    Imahashi, Nobuhiko
    Terakura, Seitaro
    Kondo, Eisei
    Kato, Koji
    Kim, Sung-Won
    Shinohara, Akihito
    Watanabe, Mizuki
    Fukuda, Takahiro
    Uchida, Naoyuki
    Kobayashi, Hikaru
    Ishikawa, Jun
    Kataoka, Keisuke
    Shiratori, Souichi
    Ikeda, Takashi
    Matsuoka, Ken-ichi
    Yoshida, Shuro
    Kondo, Tadakazu
    Kimura, Takafumi
    Onizuka, Makoto
    Ichinohe, Tatsuo
    Atsuta, Yoshiko
    Kanda, Junya
    BONE MARROW TRANSPLANTATION, 2022, 57 (02) : 243 - 251
  • [44] Second allogeneic haematopoietic stem cell transplantation using reduced-intensity conditioning regimen as treatment for haematological malignancies relapsing following first allogeneic haematopoietic stem cell transplantation
    Katayama, Y.
    Iwato, K.
    Toishigawa, K.
    Ochi, T.
    Okatani, T.
    Imanaka, R.
    Kyo, K.
    Itagaki, M.
    Asaoku, H.
    Kyo, T.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S435 - S435
  • [45] Impact of donor types on reduced-intensity conditioning allogeneic stem cell transplant for mature lymphoid malignancies
    Nobuhiko Imahashi
    Seitaro Terakura
    Eisei Kondo
    Koji Kato
    Sung-Won Kim
    Akihito Shinohara
    Mizuki Watanabe
    Takahiro Fukuda
    Naoyuki Uchida
    Hikaru Kobayashi
    Jun Ishikawa
    Keisuke Kataoka
    Souichi Shiratori
    Takashi Ikeda
    Ken-ichi Matsuoka
    Shuro Yoshida
    Tadakazu Kondo
    Takafumi Kimura
    Makoto Onizuka
    Tatsuo Ichinohe
    Yoshiko Atsuta
    Junya Kanda
    Bone Marrow Transplantation, 2022, 57 : 243 - 251
  • [46] Immunomodulation in patients with solid tumour progressing after allogeneic stem cell transplantation and reduced-intensity conditioning regimen
    Sarina, B
    Mazza, R
    Castagna, L
    Todisco, E
    Bertani, G
    Timofeeva, I
    BONE MARROW TRANSPLANTATION, 2005, 35 : S203 - S203
  • [47] Leukemic relapse after allogeneic stem cell transplantation with a T-cell depleted reduced intensity conditioning (RIST) regimen
    Pollyea, DA
    Artz, AS
    Stock, W
    Godley, L
    Odenike, OM
    Rich, E
    Smith, SM
    Larson, R
    Van Besien, K
    BLOOD, 2005, 106 (11) : 572A - 572A
  • [48] Serotherapy vs. ex vivo T-cell depletion in unrelated donor marrow transplantation for pediatric hematologic malignancies.
    Przepiorka, D
    Khan, SP
    Rooney, C
    Kuehnle, I
    Heslop, H
    Gottschalk, S
    Bollard, C
    Brenner, MK
    Krance, R
    BLOOD, 2002, 100 (11) : 637A - 638A
  • [49] Thiotepa and fludarabine as reduced-intensity conditioning regimen followed by allogeneic peripheral stem cell transplantation for hematologic malignancies
    Alessandrino, EP
    Bernasconi, P
    Colombo, AA
    Caldera, D
    Malcovati, L
    Varettoni, M
    Rumi, E
    Baraté, C
    Ardizzone, F
    Lazzarino, M
    BONE MARROW TRANSPLANTATION, 2003, 31 : S155 - S155